Table I.

Clinicopathological features of endometrioid adenocarcinoma with choriocarcinomatous differentiation.

Case no.	Age (years)	Histopathology of coexisting tumor	Metastases or invasion	Histopathology at metastatic sites	Outcome, months	Reference
1	70	WD	Brain, lung, liver, kidneys	Choriocarcinoma	DOD, 14	9
2	78	PD	Pelvic lymph nodes	NA	DOD, 1.5	10
3	48	PD	Lungs	NA	AWD, 2	10
4	63	Adenocarcinoma	Lungs, liver, peritoneum	Same as primary site	DOD, 14	10
5	83	MD	Lungs	NA	AWD, 1	11
6	68	PD, clear cell and serous papillary	Pelvic lymph nodes	Serous papillary adenocarcinoma	NED, 16	12
7	54	MD	Retroperitoneum	Adenocarcinoma	DOD, 24	13
8	58	WD	Vaginal cuff	Choriocarcinoma	NED, 36	14
9	42	MD	None		NED, 6	15
Present case	59	PD	Iliac and paraaortic lymph nodes	Same as primary site	NED, 2

WD, well-differentiated adenocarcinoma; PD, poorly-differentiated adenocarcinoma; MD, moderately-differentiated adenocarcinoma; NA, not available; AWD, alive with disease; DOD, died of disease; NED, no evidence of disease.